Zika Virus Vaccines Market Explore Future Growth by Global Top Players - Sanofi Pasteur, ImmunoVaccines Inc, Inovio Pharmaceuticals, Inc, Valneva, Bharat Biotech International Pvt. Ltd., NewLink Genetics

Worldwide Market Reports has announced the addition of the “Zika Virus Vaccines by Company Profile, Deals Type, Funding, Clinical Trials Insight, Regulatory Landscape & Recent Development”, Report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create value in your business.

Publisher’s Zika Virus Vaccines market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.

The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.

The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players.

Request a Sample Copy: https://www.worldwidemarketreports.com/sample/56741

Zika virus is an emerging viral disease that is transmitted through the bite of an infected mosquito, primarily Aedes aegypti, the same vector that transmits chikungunya, dengue and yellow fever. Zika has a similar epidemiology, clinical presentation and transmission cycle in urban environments as chikungunya and dengue, although it generally causes milder illness.

The highest risk is to pregnant women due to the connection the virus has with serious birth defects. Pregnant women who contract the virus have a high possibility of giving birth to a baby with microcephaly, a neurodevelopment disorder, where a baby is born with an unusually small head due to abnormal brain development in the womb or after birth. Complications of this disorder include seizures and developmental issues.

Due to the serious nature of global risk, the WHO has declared the microcephaly cases associated with the Zika virus a Public Health Emergency of International Concern (PHEIC). With no vaccines or cure the virus and its risks are expected to continue to spread. The WHO is predicting up to 4 Million Zika cases in the Americas by 2016 and the World Bank is projecting the short-term economic impact for 2016, in Latin America and the Caribbean to be about US$3.5 Billion.

With fears of Zika virus reaching new heights, Zika virus vaccines are gaining popularity. Many Government agencies and research institutes support pharmaceutical companies for the development & manufacturing of Zika virus vaccines. It is predicted that Zika virus vaccines shot will available to the public by 2018.

The research report presents a comprehensive study of the Zika virus vaccines with details. It provides essential insights of introduction of Zika virus, current situation and areas with Zika virus and funding in Zika virus vaccines research. Additionally, the report includes assessment of clinical trials and regulatory landscape of Zika virus vaccines development. Key trends in terms of partnerships, collaborations and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the Zika virus vaccines development such as Sanofi Pasteur, ImmunoVaccines Inc, Inovio Pharmaceuticals, Inc, Valneva, Bharat Biotech International Pvt. Ltd., NewLink Genetics. The major players are evaluated on various parameters such as company overview, product outlook and Zika virus vaccines latest development and trends.

Table of Contents

1. Executive Summary
2. Zika Virus - Introduction, Signs and Symptoms, Transmission, Diagnosis, Treatment & Prevention
3. Current Situation & Areas with Zika Virus
4. Competitive Landscape of The Zika Virus Vaccines Companies
5. Funding in Zika Virus Vaccines Research
6. Zika Virus Vaccines - Clinical Trials Insight by Phase & Trial Status
7. Zika Virus Vaccines - Regulatory Landscape
8. Key Companies Analysis
8.1 Sanofi Pasteur
8.1.1 Business Overview
8.1.2 Zika Virus Vaccines - Latest Development and Trends
8.2 ImmunoVaccines Inc.

Else place an Inquire before Purchase “Zika Virus Vaccines by Company Profile, Deals Type, Funding, Clinical Trials Insight, Regulatory Landscape & Recent Development": https://www.worldwidemarketreports.com/quiry/56741

About Us:
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Mr. Shah
Worldwide Market Reports
Tel: +1 415 871 0703
Email: sales@worldwidemarketreports.com
Visit our new Website: www.coherentwire.com

This release was published on openPR.